Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-22-007127
Filing Date
2022-12-20
Accepted
2022-12-20 15:50:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9893441_13-g.htm SC 13G 68656
  Complete submission text file 0000919574-22-007127.txt   70028
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88207 | Film No.: 221474583
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
KOTLER KEVIN (Filed by) CIK: 0001601692 (see all company filings)

Type: SC 13G